Marken formally opens new clinical-distribution service depot in Buenos Aires
Plans to continue expanding in Europe, Asia and Americas
Marken (London; US HQ in New York) has opened a purpose-built, GMP-compliant facility in Argentina to handle the 1,200 clinical trials it is currently providing services for in Latin America, and as a platform for future growth in the region; another facility was opened previously in Mexico City. The new facility includes a full range of temperature controlled storage (ambient, refrigerated and frozen); a secure area for controlled substances; and pick&pack, relabeling, reverse logistics; and specimen kit distribution and storage.
Marken’s distribution network handles 6,000 clinical trials globally, according to the company, and is emphasizing its access to “treatment naïve” geographies around the world. Although the current emphasis is on clinical trials support, the company is also building capabilities for handling commercial distribution and logistics, especially for biologic products. Temperature-controlled shipping options the company provides for APIs and finished goods include Envirotainer containers and unit-load devices (ULDs); Luftansa UniCooler ULDs, and containers from Acutemp, Minnesota Thermal Science, Kryotrans and Laminar Medica.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
